But since Russia is so heavily experienced with FDA trials and reporting in English to CROs from those prior trials, I would expect they have pretty well worked all the bugaboos in the communication/database end of the reporting.
Not as though this is their first rodeo. That is why I believe CRO may be a bit further along in the data analysis than we have heard.
Sorry, hadn't read JFMs two prior posts. My thinking is along his line of thinking.
(3)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links